About this trial
The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.
Eligibility criteria
Qualifiers
Signed informed consent for the data collection and participation in the SHCS (Cohort consent).
Signed informed consent to be randomized to future interventions (Randomization consent).
Age 18 years or older.
Smoked one or more tobacco cigarettes per day (smoking status = yes) at the time of enrolment.
Disqualifiers
Currently using e-cigarettes or nicotine pouches or nicotine patches.
Pregnant women.
Trial design
Treatments tested in this trial
- tobacco smoking substitution products
Treatment groups
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
Swiss National Science Foundation
Collaborator
Novartis Foundation for Medical-Biological Research
Collaborator